Implantable Cardioverter-Defibrillator Use in the VA System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01217827|
Recruitment Status : Completed
First Posted : October 8, 2010
Results First Posted : December 7, 2016
Last Update Posted : May 19, 2021
|Condition or disease||Intervention/treatment||Phase|
|Cardiomyopathies||Behavioral: Clinical Reminder||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||89 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||Implantable Cardioverter-Defibrillator (ICD) Utilization in a Potentially Eligible VA Population|
|Study Start Date :||April 2010|
|Actual Primary Completion Date :||January 2011|
|Actual Study Completion Date :||December 2013|
Experimental: Clinical Reminder
Reminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient.
Behavioral: Clinical Reminder
No Intervention: Control
This group does not receive an intervention.
- Referral for Implantable Cardioverter Defibrillator [ Time Frame: 6 months ]Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01217827
|United States, California|
|VA Palo Alto Health Care System|
|Palo Alto, California, United States, 94304|
|Stanford University School of Medicine|
|Stanford, California, United States, 94305|
|Principal Investigator:||Paul A. Heidenreich||Stanford University|